IBD Inflammatory Bowel Disease & Primary Sclerosing Cholangitis (PSC) Webcast 2.18.21

February 18, 2021

Target Audience

This gastroenterologist education program is designed for physicians committed to Crohn’s

disease, ulcerative colitis (IBD), and primary sclerosing cholangitis (PSC) patient care. Regional

gastroenterologists, colorectal surgeons, hepatologists & subspecialty medical professionals are welcome.

 

 

Learning Objectives

 

Objectives:

· Explore disease relationships between IBD and PSC.

· Discuss biliary complications of IBD and PSC.

· Explore cancer risk and monitoring for IBD and PSC patients.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 Attendance
Course opens: 
01/26/2021
Course expires: 
06/30/2021
Event starts: 
02/18/2021 - 7:00pm
Event ends: 
02/18/2021 - 8:00pm

7:00 IBD Collaborative: Welcome Sandra El-Hachem, MD and Marc Schwartz, MD

7:05 Primary Sclerosing Cholangitis (PSC) & IBD Cristina Strahotin, MD

7:15 Biliary Complications of PSC & IBD Jennifer Chennat, MD

7:25 Cancer Surveillance in IBD Marc Schwartz, MD

7:40 Q&A and Discussion with Course Attendees

8:00 Adjourn

 

Webcast
Pittsburgh, PA
United States

Marc Schwartz, MD - Assistant Professor of Medicine - Div. of GI, Hepatology & Nutrition - Univ of Pittsburgh/UPMC

Sandra El-Hachem, MD - Assistant Professor of Medicine – AHN GI Division

Cristina Strahotin, MD – Assistant Professor of Medicine – AHN Liver Group

Jennifer Chennat, MD – Associate Professor of Medicine – Div. of GI, Hepatology and Nutrition – Univ of Pittsburgh/UPMC

 

Disclosures: The following relevant relationships were with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients were disclosed:

· Sandra El-Hachem, MD, is a member of the following speakers’ bureau: AbbVie, Janssen Biotech, Takeda, UCB, Pfizer, Prometheus

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial

relationships to disclose.

 

Accreditation and credit designation 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician (CME) 

The University of Pittsburgh School designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.    

Other Healthcare Professionals 

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity. 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 Attendance

 

Gold-Level Exhibit Partners

Ferring Pharmaceuticals 

Takeda Pharmaceuticals I 

Takeda Pharmaceuticals II 

Silver-Level Exhibit Partners 

ABBVIE INC 

Janssen Biotech 

Salix

 

Please login or register to take this course.